| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activated protein C inhibits mesothelial-to-mesenchymal transition in experimental peritoneal fibrosis
|
Giri, Hemant
|
|
|
21 |
1 |
p. 133-144
|
artikel
|
| 2 |
Allosteric modulation of exosite 1 attenuates polyphosphate-catalyzed activation of factor XI by thrombin
|
Yin, Ruiqi
|
|
|
21 |
1 |
p. 83-93
|
artikel
|
| 3 |
Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome
|
Constantinescu-Bercu, Adela
|
|
|
21 |
1 |
p. 94-100
|
artikel
|
| 4 |
Blood component requirements in liver transplantation: effect of 2 thromboelastometry-guided strategies for bolus fibrinogen infusion—the TROMBOFIB randomized trial
|
Caballero, Marta
|
|
|
21 |
1 |
p. 37-46
|
artikel
|
| 5 |
Challenges in the management of women with type 2B von Willebrand disease during pregnancy and the postpartum period: evidence from literature and data from an international registry and physicians’ survey—communication from the Scientific and Standardization Committees of the International Society on Thrombosis and Haemostasis
|
Miljic, Predrag
|
|
|
21 |
1 |
p. 154-163
|
artikel
|
| 6 |
Choline and trimethylamine N-oxide impair metabolic activation of and platelet response to clopidogrel through activation of the NOX/ROS/Nrf2/CES1 pathway
|
Ge, Peng-Xin
|
|
|
21 |
1 |
p. 117-132
|
artikel
|
| 7 |
Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis
|
Iba, Toshiaki
|
|
|
21 |
1 |
p. 145-153
|
artikel
|
| 8 |
“Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia”: comment from Beyan and Beyan
|
Beyan, Cengiz
|
|
|
21 |
1 |
p. 183-184
|
artikel
|
| 9 |
“Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia”: reply
|
Mahamad, Syed
|
|
|
21 |
1 |
p. 185
|
artikel
|
| 10 |
Factor V Leiden-independent activated protein C resistance: Communication from the plasma coagulation inhibitors subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation Committee
|
Moore, Gary W.
|
|
|
21 |
1 |
p. 164-174
|
artikel
|
| 11 |
Guiding fibrinogen replacement by rotational thromboelastometry in liver transplantation: bridging the evidence gaps
|
Reddy, Sundara
|
|
|
21 |
1 |
p. 24-25
|
artikel
|
| 12 |
Happy 20th Anniversary, JTH!
|
Lillicrap, David
|
|
|
21 |
1 |
p. 1
|
artikel
|
| 13 |
Heparin and heparin proteoglycan-mimetics activate platelets via PEAR1 and PI3Kβ
|
Kardeby, Caroline
|
|
|
21 |
1 |
p. 101-116
|
artikel
|
| 14 |
“Hereditary angioedema is associated with an increased risk of venous thromboembolism”: comment from Petersen et al.
|
Petersen, Remy S.
|
|
|
21 |
1 |
p. 179
|
artikel
|
| 15 |
“Hereditary angioedema is associated with an increased risk of venous thromboembolism”: reply
|
Grover, Steven P.
|
|
|
21 |
1 |
p. 180-182
|
artikel
|
| 16 |
High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism
|
Whitworth, Hilary
|
|
|
21 |
1 |
p. 47-56
|
artikel
|
| 17 |
Issue Information
|
|
|
|
21 |
1 |
p. e1-e5
|
artikel
|
| 18 |
ISTH News and Updates: Join the ISTH Today
|
|
|
|
21 |
1 |
p. 192-193
|
artikel
|
| 19 |
MicroRNAs as prognostic biomarkers for (cancer–associated) venous thromboembolism
|
Anijs, Rayna J.S.
|
|
|
21 |
1 |
p. 7-17
|
artikel
|
| 20 |
Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study
|
Bistervels, Ingrid M.
|
|
|
21 |
1 |
p. 57-67
|
artikel
|
| 21 |
Prevalence of pulmonary embolism among patients with recent onset of dyspnea on exertion. A cross-sectional study
|
Prandoni, Paolo
|
|
|
21 |
1 |
p. 68-75
|
artikel
|
| 22 |
Rivaroxaban and apixaban are less effective than enoxaparin for the prevention of catheter-induced clotting in vitro
|
Guan, Zeyu
|
|
|
21 |
1 |
p. 76-82
|
artikel
|
| 23 |
Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia
|
Virk, Zain M.
|
|
|
21 |
1 |
p. 26-36
|
artikel
|
| 24 |
Screening Pulmonary Embolism in Patients with Recent Onset Dyspnea: Should We Do More?
|
Zhu, Yong-Jian
|
|
|
21 |
1 |
p. 21-23
|
artikel
|
| 25 |
Targeting the von Willebrand Factor–ADAMTS-13 axis in sickle cell disease
|
Ellsworth, Patrick
|
|
|
21 |
1 |
p. 2-6
|
artikel
|
| 26 |
“The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study”: comment from Violi et al.
|
Violi, Francesco
|
|
|
21 |
1 |
p. 186-187
|
artikel
|
| 27 |
“The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study”: reply
|
Driever, Ellen G.
|
|
|
21 |
1 |
p. 188-189
|
artikel
|
| 28 |
Thrombosis in hereditary hemorrhagic telangiectasia
|
Kroll, Caleb J.
|
|
|
21 |
1 |
p. 18-20
|
artikel
|
| 29 |
Venous thromboembolism associated with estrogen–containing contraceptives versus any hormonal risk factor: a comparison of recurrence rates
|
Wiegers, Hanke M.G.
|
|
|
21 |
1 |
p. 175-178
|
artikel
|
| 30 |
William L. Nichols, MD (1940–2022)
|
Pruthi, Rajiv K.
|
|
|
21 |
1 |
p. 190-191
|
artikel
|
Tijdschrift beschrijving